8.560USD-6.04%Mkt Cap: 684.11M USDP/E: —Last update: 2026-06-01
BridgeBio Oncology Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of small-molecule therapeutics for the treatment of renin-angiotensin system and phosphoinositide 3-kinase maligna…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap684.11M USD
Enterprise Value468.93M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-134.04M USD
Revenue/Share—
Last Price8.560 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees106
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.19
PEG—
EV/EBITDA-2.78
EV/Revenue—
P/S—
P/B1.93
EPS (TTM)-1.92
EPS (Forward)-2.14
52W Range
7.60013% of range14.87
52W High14.87 USD
52W Low7.600 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-32.61%
ROA-29.90%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-113.89M USD
CapEx (TTM)606.00K USD
FCF Margin—
FCF Yield-12.58%
Net Debt-249.63M USD
Net Debt/EBITDA1.48
Balance Sheet
Debt/Equity0.01
Current Ratio6.16
Quick Ratio5.83
Book Value/Sh4.648 USD
Cash/Share3.149 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)25.11 USD
Target Range18.00 USD – 41.00 USD
# Analysts9
Ownership
Shares Out.80.11M
Float35.75M
Insiders27.20%
Institutions68.86%
Short Interest
Short Ratio7.3d
Short % Float11.50%
Short % Out.4.09%
Shares Short3.28M
Short (prev mo.)3.24M
Technical
SMA 508.711 (-1.7%)
SMA 20010.70 (-20.0%)
Beta0.22
S&P 52W Chg27.94%
Avg Vol (30d)423.71K
Avg Vol (10d)512.62K
Technical Indicators
RSI (14)57.6
MACD0.0186
MACD Signal-0.0711
MACD Hist.+0.0896
BB Upper9.223 USD
BB Middle8.439 USD
BB Lower7.656 USD
BB Width18.56%
ATR (14)0.5866 USD
Vol Ratio (20d)0.45x